Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-8-26
pubmed:abstractText
Plasminogen activator inhibitor-1 (PAI-1) is increased in the lungs of patients with pulmonary fibrosis, and animal studies have shown that experimental manipulations of PAI-1 levels directly influence the extent of scarring that follows lung injury. PAI-1 has 2 known properties that could potentiate fibrosis, namely an antiprotease activity that inhibits the generation of plasmin, and a vitronectin-binding function that interferes with cell adhesion to this extracellular matrix protein. To determine the relative importance of each PAI-1 function in lung fibrogenesis, we administered mutant PAI-1 proteins that possessed either intact antiprotease or vitronectin-binding activity to bleomycin-injured mice genetically deficient in PAI-1. We found that the vitronectin-binding capacity of PAI-1 was the primary determinant required for its ability to exacerbate lung scarring induced by intratracheal bleomycin administration. The critical role of the vitronectin-binding function of PAI-1 in fibrosis was confirmed in the bleomycin model using mice genetically modified to express the mutant PAI-1 proteins. We conclude that the vitronectin-binding function of PAI-1 is necessary and sufficient in its ability to exacerbate fibrotic processes in the lung.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1528-0020
pubmed:author
pubmed:issnType
Electronic
pubmed:day
25
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2313-21
pubmed:meshHeading
pubmed-meshheading:21734232-Animals, pubmed-meshheading:21734232-Bleomycin, pubmed-meshheading:21734232-Bronchoalveolar Lavage Fluid, pubmed-meshheading:21734232-Collagen, pubmed-meshheading:21734232-Disease Models, Animal, pubmed-meshheading:21734232-Humans, pubmed-meshheading:21734232-Hydroxyproline, pubmed-meshheading:21734232-Lung, pubmed-meshheading:21734232-Mice, pubmed-meshheading:21734232-Mice, Inbred C57BL, pubmed-meshheading:21734232-Mice, Knockout, pubmed-meshheading:21734232-Mice, Transgenic, pubmed-meshheading:21734232-Mutant Proteins, pubmed-meshheading:21734232-Plasminogen Activator Inhibitor 1, pubmed-meshheading:21734232-Protein Binding, pubmed-meshheading:21734232-Pulmonary Fibrosis, pubmed-meshheading:21734232-Recombinant Proteins, pubmed-meshheading:21734232-Serpin E2, pubmed-meshheading:21734232-Vitronectin
pubmed:year
2011
pubmed:articleTitle
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
pubmed:affiliation
Division of Pulmonary and Critical Care Medicine. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural